Merkesdal S[au] - Search Results

Year	Number of Results
1999	1
2000	1
2001	4
2002	6
2003	6
2004	5
2005	6
2006	4
2007	1
2008	2
2009	1
2010	2
2011	1
2012	3
2013	2
2015	1
2017	1
2018	2
2019	1
2020	1
2021	1
2022	0

1

Interest of modelling in rheumatoid arthritis.

Beresniak A, Dupont DM, Becker JC, Merkesdal S. Beresniak A, et al. Among authors: merkesdal s. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S96-101. Epub 2012 Oct 18. Clin Exp Rheumatol. 2012. PMID: 23078913 Review.

2

Intraindividual Comparisons to Determine Comparative Effectiveness: Their Relevance for G-BA's Health Technology Assessments.

Wagle JA, Flacke JP, Knoerzer D, Ruof J, Merkesdal S. Wagle JA, et al. Among authors: merkesdal s. Value Health. 2021 May;24(5):744-752. doi: 10.1016/j.jval.2020.11.016. Epub 2021 Feb 18. Value Health. 2021. PMID: 33933244 Free article.

3

Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature.

Kirchhoff TD, Mittendorf T, Schmidt RE, Jablonka A, Merkesdal S. Kirchhoff TD, et al. Among authors: merkesdal s. Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):307-17. doi: 10.1586/erp.12.19. Expert Rev Pharmacoecon Outcomes Res. 2012. PMID: 22812555 Review.

4

Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy.

Radermacher LK, Ponto K, Merkesdal S, Pomart V, Frommer L, Pfeiffer N, König J, Kahaly GJ. Radermacher LK, et al. Among authors: merkesdal s. J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgz021. doi: 10.1210/clinem/dgz021. J Clin Endocrinol Metab. 2020. PMID: 31529067

5

Early arthritis and rheumatoid arthritis in Germany.

Zeidler H, Merkesdal S, Hülsemann JL. Zeidler H, et al. Among authors: merkesdal s. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S106-12. Clin Exp Rheumatol. 2003. PMID: 14969060 Review.

6

Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritis.

Merkesdal S, Ruof J, Mittendorf T, Zeidler H. Merkesdal S, et al. Expert Opin Pharmacother. 2004 Sep;5(9):1881-6. doi: 10.1517/14656566.5.9.1881. Expert Opin Pharmacother. 2004. PMID: 15330726 Review.

7

[Health economics research in the area of chronic polyarthritis].

Merkesdal S, Ruof J, Mittendorf T, Mau W, Zeidler H. Merkesdal S, et al. Z Rheumatol. 2002 Feb;61(1):21-9. doi: 10.1007/s003930200003. Z Rheumatol. 2002. PMID: 11974488 Review. German.

8

Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis.

Merkesdal S, Ruof J, Huelsemann JL, Schoeffski O, Maetzel A, Mau W, Zeidler H. Merkesdal S, et al. J Rheumatol. 2001 Mar;28(3):657-61. J Rheumatol. 2001. PMID: 11296977 Review.

9

Public health relevance of Graves' orbitopathy.

Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ. Ponto KA, et al. Among authors: merkesdal s. J Clin Endocrinol Metab. 2013 Jan;98(1):145-52. doi: 10.1210/jc.2012-3119. Epub 2012 Nov 26. J Clin Endocrinol Metab. 2013. PMID: 23185037

10

Pregnancy Related Health Care Needs in Refugees-A Current Three Center Experience in Europe.

Dopfer C, Vakilzadeh A, Happle C, Kleinert E, Müller F, Ernst D, Schmidt RE, Behrens GMN, Merkesdal S, Wetzke M, Jablonka A. Dopfer C, et al. Among authors: merkesdal s. Int J Environ Res Public Health. 2018 Sep 5;15(9):1934. doi: 10.3390/ijerph15091934. Int J Environ Res Public Health. 2018. PMID: 30189649 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results